NDAQ:CMND - Post Discussion
Post by
whytestocks on Aug 21, 2024 4:17pm
Clearmind Medicine Granted U.S. Patent Approval for Binge Be
Breaking News: $CMND Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior TreatmentVancouver, Canada, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to solve major under-treated healt...
CMND - Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment
Be the first to comment on this post